BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21634003)

  • 1. Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT.
    Stubbusch J; Majdazari A; Schmidt M; Schütz G; Deller T; Rohrer H
    Genesis; 2011 Dec; 49(12):935-41. PubMed ID: 21634003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of transient catecholaminergic cell types revealed by site-specific recombination in transgenic mice.
    Matsushita N; Kobayashi K; Miyazaki J; Kobayashi K
    J Neurosci Res; 2004 Oct; 78(1):7-15. PubMed ID: 15372500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.
    Bradley CK; Takano EA; Göthert JR; Göttgens B; Green AR; Begley CG; van Eekelen JA
    Genesis; 2007 Mar; 45(3):145-51. PubMed ID: 17330263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient inducible Pan-neuronal cre-mediated recombination in SLICK-H transgenic mice.
    Heimer-McGinn V; Young P
    Genesis; 2011 Dec; 49(12):942-9. PubMed ID: 21671347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal gene control by the Cre-ERT2 system in melanocytes.
    Yajima I; Belloir E; Bourgeois Y; Kumasaka M; Delmas V; Larue L
    Genesis; 2006 Jan; 44(1):34-43. PubMed ID: 16419042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
    Zhang H; Fujitani Y; Wright CV; Gannon M
    Genesis; 2005 Jul; 42(3):210-7. PubMed ID: 15986486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
    Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
    Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium.
    el Marjou F; Janssen KP; Chang BH; Li M; Hindie V; Chan L; Louvard D; Chambon P; Metzger D; Robine S
    Genesis; 2004 Jul; 39(3):186-93. PubMed ID: 15282745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-specific recombination by Cre recombinase inserted into the murine tau locus.
    Muramatsu K; Hashimoto Y; Uemura T; Kunii M; Harada R; Sato T; Morikawa A; Harada A
    Biochem Biophys Res Commun; 2008 Jun; 370(3):419-23. PubMed ID: 18381201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural expression of alpha-internexin promoter in vitro and in vivo.
    Wang P; Wang SM; Hsieh CJ; Chien CL
    J Cell Biochem; 2006 Feb; 97(2):275-87. PubMed ID: 16173078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HoxB8 in noradrenergic specification and differentiation of the autonomic nervous system.
    Huber L; Ferdin M; Holzmann J; Stubbusch J; Rohrer H
    Dev Biol; 2012 Mar; 363(1):219-33. PubMed ID: 22236961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.